DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/ns66j8/americas_clinical) has announced the addition of the "Americas Clinical Chemistry Analyzer Market by Product, by End-Users - Forecast to 2019" report to their offering.
The American Clinical Chemistry Analyzers market is estimated to grow at a CAGR of 5.2% from 2014 to 2019. Countries, such as the U.S., Canada, Mexico, Chile and Rest of Americas (RoA) are covered in this report.
The Americas is the largest market for clinical chemistry analyzers due to the factors such as; increasing healthcare expenditure, growing aging population, rising prevalence to various infectious diseases such as; tuberculosis, malaria, hepatitis, Rise in Rental Agreements, Also, increasing medical insurance in the U.S., and inclination towards laboratory automation in the region and developing infrastructure facilities would create a growing need for automated laboratories and analyzers as well.
Among the major countries covered, the U.S. contributed the major share, followed by Canada, while Chile is expected to grow with highest CAGR during the forecast period.
The report, Americas Clinical Chemistry Analyzers Market is broadly classified on the basis of type, technology, and end-user. On the basis of types, the market includes - Semi-automated and Fully Automated Analyzers. Further, the Fully Automated Clinical Chemistry Instruments market is segmented into Entry Level, Medium Throughput, Large High Throughput, and Ultra-Large High Throughput Analyzers on the basis of tests per hour. The market in terms of technology covers wet and dry chemistry.
The market is also segmented on the basis of major end-users of this market, such as academic research institutes, diagnostic laboratories, hospitals, among other end-users.
The report has profiled the leading players of this market along with the developments (New product launches and partnerships, agreements, collaborations, and joint ventures) undertaken by the companies over the past few years, and strategies adopted by them to sustain and strengthen their position in the clinical chemistry analyzers market. Roche Diagnostics (Switzerland), Beckman Coulter (U.S.) Abbott Diagnostics (U.S.) Siemens AG (Germany), Ortho-Clinical Diagnostics (U.S.), Thermo Fisher Scientific (U.S.) Randox Laboratories Ltd. (U.K.), ElitechGroup (France), Mindray (China), and Horiba (Japan), are some of the key players operating in this market.
For more information visit http://www.researchandmarkets.com/research/ns66j8/americas_clinical